Antibodies to type II collagen in early rheumatoid arthritis: Correlation with disease progression

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1720-1727

  Cook, Andrew D ^a   Rowley, Merrill J ^a   Mackay, Ian R ^a   Gough, Andrew ^b,c   Emery, Paul ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COLLAGEN METABOLISM; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN DENATURATION; RHEUMATOID ARTHRITIS;

EID: 0029782998     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391015     Document Type: Article

References (47)

1. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL: Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis 46:902-907, 1987
2. Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, Fujii K, Sagara M, Kobayashi S, Goto M, Nishioka K, Miyasaka N, Nagai Y: Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 33:1493-1500, 1990
3. Rowley MJ, Mackay IR, Brand CA, Bateman JF, Chan D: Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 12:65-69, 1992
4. Trentham DE, Townes AS, Kang AH: Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146:857-868, 1977
5. Stuart JM, Cremer MA, Kang AH, Townes AS: Collagen-induced arthritis in rats: evaluation of early immunologic events. Arthritis Rheum 22:1344-1351, 1979
6. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B: Immunization against heterologous type II collagen induces arthritis in mice. Nature 283:666-667, 1980
7. Yoo TJ, Kim S-Y, Stuart JM, Floyd RA, Olsen GA, Cremer MA, Kang AH: Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 168:777-782, 1988
8. Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS: Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc 59:737-743, 1984
9. Cook AD, Rowley MJ, Stockman A, Muirden KD, Mackay IR: Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol 21:1186-1191, 1994
10. Pereira RS, Black CM, Duance VC, Jones VE, Jacoby RK, Welsh LI: Disappearing collagen antibodies in rheumatoid arthritis. Lancet 2:501-502, 1985
11. Fujii K, Tsuji M, Kitamura A, Murota K: The diagnostic significance of anti-type II collagen antibody assay in rheumatoid arthritis. Int Orthop 16:272-276, 1992
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
13. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, Birley A, Emery P: Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 37:1166-1170, 1994
14. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos DG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 37:393-406, 1968
15. Fries JF: The dimensions of health outcomes: the Health Assessment Questionnaire. J Rheumatol 74:786-793, 1982
16. Steinbrocker O, Traeger CH, Batterman EC: Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949
17. Wordsworth BP, Allsop CEM, Young RP, Bell JI: HLA DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence specific oligonucleotide probes. Immunogenetics 32:413-418, 1990
18. Rowley MJ, Gershwin ME, Mackay IR: Collagen antibodies in juvenile arthritis and adult rheumatoid arthritis: differences in levels and type-specificity. J Rheumatol 15:289-293, 1988
19. Clague RB, Shaw MJ, Holt PJL: Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis 39:201-206, 1980
20. 125I-radioimmunoassay. Arthritis Rheum 26:832-840, 1983
21. Collier DH, Kerwar SS, Garovoy MR, Fyfe KH, Stobo JD: Anticollagen antibodies and immune response gene products in rheumatoid arthritis. Arthritis Rheum 27:1201-1209, 1984
22. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL: A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum 32:139-145, 1989
23. Stockman A, Rowley MJ, Emery P, Muirden KD: Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study. Rheumatol Int 8:239-243, 1989
24. Weksler ME: Age-associated changes in the immune response. J Am Geriatr Soc 30:718-723, 1982
25. Möttönen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653, 1988
26. Emery P: Early rheumatoid arthritis: therapeutic strategies. Scand J Rheumatol 23:3-7, 1994
27. Morgan K, Clague RB, Reynolds I, Davis M: Antibodies to type II collagen in early rheumatoid arthritis. Br J Rheumatol 32:333-335, 1993
28. Lipton R, LaPorte RE: Epidemiology of iset cell antibodies. Epidemiol Rev 11:182-203, 1989
29. Lendrum R, Walker G, Theophanides C, Pyke DA, Bloom A, Gamble DR: Islet-cell antibodies in diabetes mellitus. Lancet 2:1273-1276, 1976
30. Chan K-WA, Felson DT, Yood RA, Walker AM: The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814-820, 1994
31. Clague RB, Moore LJ: IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid: evidence for the presence of collagen-anticollagen immune complexes in synovial fluid. Arthritis Rheum 27:1370-1377, 1984
32. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ: Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 32: 1087-1092, 1989
33. Rönnelid J, Lynsholm J, Engström-Laurent A, Klareskog L, Heyman B: Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid: evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 37:1023-1029, 1994
34. Emmrich F, Wang J: Frequencies of autoreactive collagen type II specific B-cells in rheumatoid arthritis. Scand J Rheumatol 24:39-41, 1994
35. Jasin HE: Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 28:241-248, 1985
36. Holmdahl R, Tarkowski A, Nordling C, Rubin K, Klareskog L: Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production. Monogr Allergy 22:71-80, 1987
37. Nordling C, Holmdahl R, Klareskog L: A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies. J Immunol 146:4258-4263, 1991
38. Nordling C, Holmdahl R, Klareskog L: Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies. Immunology 72:486-490, 1991
39. Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J Exp Med 154:688-700, 1981
40. Gregersen PK, Shen M, Song QL, Merryman P, Degar S, Seki T, Maccari J, Goldberg D, Murphy H, Schwenzer J, Wang CY, Winchester RJ, Nepom GT, Silver J: Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A 83:2642-2646, 1986
41. Winchester RJ, Gregersen PK: The molecular basis of susceptibility to rheumatoid arthritis: the conformation equivalence hypothesis. Springer Semin Immunopathol 10:119-139, 1988
42. Wordsworth BP, Lanchbury JSS, Sakkas LI, Welsh KI, Bell JI: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 86:10049-10053, 1989
43. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95:2120-2126, 1995
44. Banerjee S, Luthra HS, Moore SB, O'Fallon WM: Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin Exp Rheumatol 6:373-380, 1988
45. Dyer PA, Clague RB, Klouda PT, Firth S, Harris R, Holt PJL: HLA antigens in patients with rheumatoid arthritis and antibodies to native type II collagen. Tissue Antigens 20:394-396, 1982
46. Sanders PA, Grennan DM, Klimiuk PS, Clague RB, deLange GG, Collins I, Dyer PA: Gm allotypes and HLA in RA patients with circulating antibodies to native type II collagen. Ann Rheum Dis 46:391-394, 1987
47. Klimiuk PS, Clague RB, Grennan DM, Dyer PA, Smeaton I, Harris R: Autoimmunity to native type II collagen-distinct genetic subset of rheumatoid arthritis. J Rheumatol 12:865-870, 1985